These data, derived from 45 patients, with an R2 of 0.51, suggest that GDF-15 induction could be utilised as a prospective marker in the identification of patients at higher risk of developing delayed thrombocytopenia. This evidence concerns the gene GDF15 and Thrombocytopenia.